AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

IOFINA PLC

Business and Financial Review Jun 16, 2015

7716_rns_2015-06-16_0cdddd10-a8ea-4f55-a21f-1be77c3f6721.html

Business and Financial Review

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2336Q

Iofina PLC

16 June 2015

16 June 2015

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

IODINE PRODUCTION UPDATE

H1 production target increased

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to issue an update to the market today on the Company's Iodine Production.

The Board announces today that the Company expects to exceed the upper end of its production target of 220-260 metric tons of crystalline iodine in H1 of 2015 from its IOsorb® plants.  The Company now expects to produce over 280 metric tons of crystalline iodine in the period. 

Commenting on today's news, President and CEO Dr. Tom Becker, stated: "We are pleased that our focused operations in our core production area have resulted in increased efficiencies and production volumes exceeding our previous target.  Production to date underpins our financial expectations for the current financial year.  With increased production and inventory levels, we are now positioned to pursue additional external sales and off-take agreements of our produced iodine."

For further information, please contact:                                                                                             

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

Christopher Raggett/Giles Rolls/Joanna Weaving

finnCap Ltd

Tel: +44 (0)20 7220 0500

Rob Collins/Emily Morris

GMP Securities

Tel: +44(0)20 7647 2800

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCDMGMVNKRGKZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.